The effects of booster vaccination on combined hepatitis A and hepatitis B vaccine in both anti-HBs and anti-HAV negative children 5-15 years after hepatitis B vaccine primary immunization
In the present study, we investigated the changes in both anti-HAV lgG and anti-HBs lgG levels and compared the antibody seroconversion rates of different doses of combined hepatitis A and hepatitis B vaccine in children. Children who were vaccinated as infants with Hepatitis B vaccine were revaccin...
Saved in:
Published in | Human vaccines & immunotherapeutics Vol. 9; no. 4; pp. 898 - 902 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.04.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In the present study, we investigated the changes in both anti-HAV lgG and anti-HBs lgG levels and compared the antibody seroconversion rates of different doses of combined hepatitis A and hepatitis B vaccine in children. Children who were vaccinated as infants with Hepatitis B vaccine were revaccinated at 5-15 y of age, then the antibody titers were monitored. Among 283 children, this study found that the anti-HAV seroconversion rates (defined as anti-HAV ≥ 1 mIU/ml) after the first and the third dose were 79.9% and 100% respectively; these observed differences were statistically significant (P<0.05); the corresponding geometric mean titers (GMTs) were 4.72 ± 2.63 mIU/ml and 13.46 ± 1.16 mIU/ml respectively. The anti-HBs seroconversion rates (defined as an anti-HBs ≥ 10 mIU/ml) were 82.3% and 99.0% respectively; these observed differences were statistically significant (P<0.05); and the corresponding titers were 319.95 ± 5.16 mIU/ml and 418.59 ± 3.89 mIU/ml respectively. After the first booster dose, the difference in anti-HAV seroconversion rate was statistically significant in children aged 5-9 y and 10-15 y (P<0.05), as was the difference of anti-HBs seroconversion, whereas after the third dose the difference was not statistically significant (P>0.05). This study demonstrated that the immunization effects of booster vaccination with combined hepatitis A and hepatitis B vaccine is successful for children. A single booster dose is adequate for younger children, while three doses are needed for older children. |
---|---|
AbstractList | In the present study, we investigated the changes in both anti-HAV lgG and anti-HBs lgG levels and compared the antibody seroconversion rates of different doses of combined hepatitis A and hepatitis B vaccine in children. Children who were vaccinated as infants with Hepatitis B vaccine were revaccinated at 5-15 y of age, then the antibody titers were monitored. Among 283 children, this study found that the anti-HAV seroconversion rates (defined as anti-HAV ≥ 1 mIU/ml) after the first and the third dose were 79.9% and 100% respectively; these observed differences were statistically significant (P<0.05); the corresponding geometric mean titers (GMTs) were 4.72 ± 2.63 mIU/ml and 13.46 ± 1.16 mIU/ml respectively. The anti-HBs seroconversion rates (defined as an anti-HBs ≥ 10 mIU/ml) were 82.3% and 99.0% respectively; these observed differences were statistically significant (P<0.05); and the corresponding titers were 319.95 ± 5.16 mIU/ml and 418.59 ± 3.89 mIU/ml respectively. After the first booster dose, the difference in anti-HAV seroconversion rate was statistically significant in children aged 5-9 y and 10-15 y (P<0.05), as was the difference of anti-HBs seroconversion, whereas after the third dose the difference was not statistically significant (P>0.05). This study demonstrated that the immunization effects of booster vaccination with combined hepatitis A and hepatitis B vaccine is successful for children. A single booster dose is adequate for younger children, while three doses are needed for older children. |
Author | Lv, Huakun Yao, Jun Xia, Shichang Chen, Yongdi Cheng, Suyun Liang, Xiaofeng Wang, Fuzhen Shen, Lingzhi Gu, Hua Cui, Fujiang |
Author_xml | – sequence: 1 givenname: Yongdi surname: Chen fullname: Chen, Yongdi organization: Zhejiang Provincial Center for Disease Prevention and Control; Hangzhou, P.R. China – sequence: 2 givenname: Hua surname: Gu fullname: Gu, Hua – sequence: 3 givenname: Suyun surname: Cheng fullname: Cheng, Suyun – sequence: 4 givenname: Lingzhi surname: Shen fullname: Shen, Lingzhi – sequence: 5 givenname: Fujiang surname: Cui fullname: Cui, Fujiang – sequence: 6 givenname: Fuzhen surname: Wang fullname: Wang, Fuzhen – sequence: 7 givenname: Jun surname: Yao fullname: Yao, Jun – sequence: 8 givenname: Shichang surname: Xia fullname: Xia, Shichang – sequence: 9 givenname: Huakun surname: Lv fullname: Lv, Huakun – sequence: 10 givenname: Xiaofeng surname: Liang fullname: Liang, Xiaofeng |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23295964$$D View this record in MEDLINE/PubMed |
BookMark | eNptUE1Lw0AQXUSxtRb8BbJHL6nZj2y6x7aoFQpeqngL2c3ErCSbmE0K9bf541zbCB4cBoaZee_N8C7Qqa0tIHRFwhkngtwWuxllRLITNKZE8CCK-OsITZ17D33EIeVCnKMRZVRGUvAx-toWgCHPQXcO1zlWde06aPEu1drYtDO1xT51XSljIcMFNH7YGYcXOLV_--XAAWysl-kKv-9MsF66A_DYLF6whTfP2AHWhSmzFiyOAhLhPaStR-Y_x_8TbVpTpe0em6rqrfk8fHaJzvK0dDAd6gQ9399tV-tg8_TwuFpsgoYS0gVKUamJpjImoXdlrulca8KEyGIilNSCcJpLJVUm9FxHnMgwBZ2p2M8FyyM2QTdH3aatP3pwXVIZp6EsUwt17xLCOePeXsY89HqA9qqCLBneTn4dZ9_M6oQK |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.4161/hv.23193 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2164-554X |
EndPage | 902 |
ExternalDocumentID | 23295964 |
Genre | Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 00X 0VX 0YH 30N 4.4 53G AALUX ABEIZ ABUPF ACENM ACGFS ADBBV ADCVX AECIN AENEX AEXWM AGYJP AIJEM ALMA_UNASSIGNED_HOLDINGS ALQZU AOIJS ARJSQ BABNJ BAWUL BLEHA BOHLJ CCCUG CGR CUY CVF DGEBU DIK EBS ECM EIF EJD EMOBN GROUPED_DOAJ H13 HYE IPNFZ KYCEM LJTGL M4Z NPM O9- OK1 OVD RIG RPM SV3 TDBHL TEORI TFL TFW TTHFI 7X8 |
ID | FETCH-LOGICAL-p211t-bb29c1c297102168c28cc1366d716b9c6142f9b9bd6c8c54190aecdb714263f53 |
IngestDate | Sat Aug 17 02:45:05 EDT 2024 Sat Sep 28 07:52:24 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | anti-HBs booster vaccination combined hepatitis A and hepatitis B vaccine anti-HAV effect |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p211t-bb29c1c297102168c28cc1366d716b9c6142f9b9bd6c8c54190aecdb714263f53 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-News-1 ObjectType-Feature-3 content type line 23 |
PMID | 23295964 |
PQID | 1443400733 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_1443400733 pubmed_primary_23295964 |
PublicationCentury | 2000 |
PublicationDate | 2013-Apr 20130401 |
PublicationDateYYYYMMDD | 2013-04-01 |
PublicationDate_xml | – month: 04 year: 2013 text: 2013-Apr |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Human vaccines & immunotherapeutics |
PublicationTitleAlternate | Hum Vaccin Immunother |
PublicationYear | 2013 |
References | 10571600 - Aliment Pharmacol Ther. 1999 Nov;13(11):1445-9 15231119 - Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Jun;25(6):470-3 17707557 - Vaccine. 2007 Oct 10;25(41):7160-7 19892043 - Vaccine. 2010 Jan 8;28(3):730-6 1408488 - Pediatr Infect Dis J. 1992 Oct;11(10):866-74 12192159 - Pediatr Infect Dis J. 2002 Aug;21(8):727-30 10547415 - Vaccine. 1999 Nov 12;18(7-8):581-7 11375963 - Gastroenterology. 2001 Jun;120(7):1828-53 19817017 - Wkly Epidemiol Rec. 2009 Oct 1;84(40):405-19 20153793 - Vaccine. 2010 Apr 1;28(16):2860-4 16014593 - JAMA. 2005 Jul 13;294(2):194-201 21989290 - Hum Vaccin. 2011 Oct;7(10):1055-9 15807160 - Przegl Epidemiol. 2004;58 Suppl 1:66-70 15755592 - Vaccine. 2005 Mar 18;23(17-18):2185-9 16162883 - N Engl J Med. 2005 Sep 15;353(11):1124-34 10048681 - Pediatr Infect Dis J. 1999 Feb;18(2):109-14 18377352 - Expert Rev Vaccines. 2007 Dec;6(6):891-902 20077662 - Zhongguo Yi Miao He Mian Yi. 2009 Apr;15(2):152-8 19729084 - Vaccine. 2009 Nov 5;27(47):6550-7 12057615 - Vaccine. 2002 Jun 7;20(19-20):2579-84 19469708 - J Infect Dis. 2009 Jul 1;200(1):39-47 10534356 - Hepatology. 1999 Nov;30(5):1312-7 17920732 - Vaccine. 2007 Nov 19;25(47):8085-90 11027806 - Vaccine. 2000 Oct 15;19(4-5):437-41 18444799 - J Infect Dis. 2008 May 15;197(10):1419-26 |
References_xml | |
SSID | ssj0000702466 |
Score | 1.9661341 |
Snippet | In the present study, we investigated the changes in both anti-HAV lgG and anti-HBs lgG levels and compared the antibody seroconversion rates of different... |
SourceID | proquest pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 898 |
SubjectTerms | Adolescent Child Child, Preschool Female Hepatitis A Antibodies - blood Hepatitis A Vaccines - administration & dosage Hepatitis A Vaccines - immunology Hepatitis B Antibodies - blood Hepatitis B Vaccines - administration & dosage Hepatitis B Vaccines - immunology Humans Immunization, Secondary - methods Immunoglobulin G - blood Male Time Factors Vaccines, Combined - administration & dosage Vaccines, Combined - immunology |
Title | The effects of booster vaccination on combined hepatitis A and hepatitis B vaccine in both anti-HBs and anti-HAV negative children 5-15 years after hepatitis B vaccine primary immunization |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23295964 https://search.proquest.com/docview/1443400733 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3datswFBZZx2A3Y_9t1xYNdhfczbIkW5dJaQmjyy6WjOzKWLKT-MYus11IHqpPsIfbkSw7Gs2gGwQTGelAcj4ffUc-Pwh9WIYRZwFLdaHbABwUGnoJqN2ThPhKAAEJqU5w_jLlkzn9vGCLweDOiVpqanmutnvzSv5Hq3AP9KqzZP9Bs71QuAHfQb9wBQ3D9cE6dgIygDDrsgfD20SpvLBc0ISZg_sLxHKd6fDpOq_AGujz8t14bNeYCiKyNOlude5NxpUt5qoHo-_DIlu1hcL7HHDm-Wy4gcelsu3G9wm9sSUtcpOMst2BwbLi9k2CnV0ZNJqpbnZYz_0vbD7Jj7JYpXkfP9SYTbRJ3GntSXizafon4JtdDC74arvO3TMP3X-iD5XJjG0k4OV5wIQWriEXDl6pY5Sjts-13d-FyfC-t3VoRw_0vb49B8bbNm38szr39Gt8Nb--jmeXi9kj9JiEgukQ0uDTtD_TA_NJKOdtjWMt8GMn7u_-i-Exs-fomXVA8KhF0ws0yIqX6EnbknTzCv0CTGGLKVwuscUUdjCF4dNhCvfqxiMMUHHGY7smw3mBNaZwhykzscMU7jCFO0xhjSlsMIUNpvYKtZjCLqZeo_nV5exi4tkOH94N8f3ak5II5SsiNM_1eaRIpJQfcJ6CGy-FAu5IlkIKmXIVKUaBvSaZSmXo6z4DSxa8QQdFWWSHCDPw2wP4e1KaUMpoGiWSC5EKwpNU0_wj9L7TQAwWVL8WS4qsbCpwfmlATfPSI_S2VU1sf0MM_oYAyfT4Aavfoac7rJ6gg_pnk50CY63lmYHJb_4OoAg |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Taylor & Francis |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effects+of+booster+vaccination+on+combined+hepatitis+A+and+hepatitis+B+vaccine+in+both+anti-HBs+and+anti-HAV+negative+children+5-15+years+after+hepatitis+B+vaccine+primary+immunization&rft.jtitle=Human+vaccines+%26+immunotherapeutics&rft.au=Chen%2C+Yongdi&rft.au=Gu%2C+Hua&rft.au=Cheng%2C+Suyun&rft.au=Shen%2C+Lingzhi&rft.date=2013-04-01&rft.eissn=2164-554X&rft.volume=9&rft.issue=4&rft.spage=898&rft.epage=902&rft_id=info:doi/10.4161%2Fhv.23193&rft.externalDBID=NO_FULL_TEXT |